Mucosal defences against Giardia

Parasite Immunology

Volumn 25, Issue 5, 2003, Pages 259-270

  Eckmann, Lars ^a,b  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Epithelial cells; Giardiasis; Mucosal immunology; Pathogenesis; Small intestine

Indexed keywords

ALPHA DEFENSIN; IMMUNOGLOBULIN A ANTIBODY; LACTOFERRIN; NITRIC OXIDE; PEPTIDE; POLYPEPTIDE ANTIBIOTIC AGENT; SECRETORY IMMUNOGLOBULIN; UNCLASSIFIED DRUG;

ADJUVANT THERAPY; ANIMAL MODEL; B LYMPHOCYTE; DIARRHEA; EFFECTOR CELL; EPIGASTRIC PAIN; ERADICATION THERAPY; GIARDIA LAMBLIA; GIARDIASIS; HOST RESISTANCE; HUMORAL IMMUNITY; IMMUNOLOGY; INFLAMMATION; INTESTINE; INTESTINE EPITHELIUM; INTESTINE EPITHELIUM CELL; INTESTINE INFECTION; INTESTINE MUCOSA; LIFE CYCLE; MUCUS; NAUSEA; PANETH CELL; PATHOGENESIS; PRIORITY JOURNAL; PROTOZOON; REINFECTION; REVIEW; SYMPTOMATOLOGY; VACCINATION; VOMITING; WEIGHT REDUCTION;

ANIMALS; EPITHELIAL CELLS; GIARDIA LAMBLIA; GIARDIASIS; HUMANS; IMMUNITY, MUCOSAL; INTESTINE, SMALL;

ANIMALIA; GIARDIA; GIARDIA INTESTINALIS; PROTOZOA;

EID: 0346249810     PISSN: 01419838     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3024.2003.00634.x     Document Type: Review

References (87)

1. Adam RD. Biology of Giardia lamblia. Clin Microbiol Rev 2001; 14: 447-475.
2. Faubert G. Immune response to Giardia duodenalis. Clin Microbiol Rev 2000; 13: 35-54.
3. Flanagan PA. Giardia - diagnosis, clinical course and epidemiology. A review. Epidemiol Infect 1992; 109: 1-22.
4. Thompson RC. Giardiasis as a re-emerging infectious disease and its zoonotic potential. Int J Parasitol 2000; 30: 1259-1267.
5. Slifko TR, Smith HV & Rose JB. Emerging parasite zoonoses associated with water and food. Int J Parasitol 2000; 30: 1379-1393.
6. Nash TE, Herrington DA, Losonsky GA & Levine MM. Experimental human infections with Giardia lamblia. J Infect Dis 1987; 156: 974-984.
7. Gillin FD, Reiner DS & McCaffery JM. Cell biology of the primitive eukaryote Giardia lamblia. Annu Rev Microbiol 1996; 50: 679-705.
8. Oberhuber G, Kastner N & Stolte M. Giardiasis, a histologic analysis of 567 cases. Scand J Gastroenterol 1997; 32: 48-51.
9. Hardin JA, Buret AG, Olson ME, Kimm MH & Gall DG. Mast cell hyperplasia and increased macromolecular uptake in an animal model of giardiasis. J Parasitol 1997; 83: 908-912.
10. Venkatesan P, Finch RG & Wakelin D. A comparison of mucosal inflammatory responses to Giardia muris in resistant B10 and susceptible BALB/c mice. Parasite Immunol 1997; 19: 137-143.
11. Scott KG, Logan MR, Klammer GM, Teoh DA & Buret AG. Jejunal brush border microvillous alterations in Giardia muris-infected mice: role of T lymphocytes and interleukin-6. Infect Immun 2000; 68: 3412-3418.
12. Nain CK, Dutt P & Vinayak VK. Alterations in enzymatic activities of the intestinal mucosa during the course of Giardia lamblia infection in mice. Ann Trop Med Parasitol 1991; 85: 515-522.
13. Byrd LG, Conrad JT & Nash TE. Giardia lamblia infections in adult mice. Infect Immun 1994; 62: 3583-3585.
14. Hill DR, Guerrant RL, Pearson RD & Hewlett EL. Giardia lamblia infection of suckling mice. J Infect Dis 1983; 147: 217-221.
15. Singer SM & Nash TE. The role of normal flora in Giardia lamblia infections in mice. J Infect Dis 2000; 181: 1510-1512.
16. Lecuit M, Dramsi S, Gottardi C, Fedor-Chaiken M, Gumbiner B & Cossart P. A single amino acid in E-cadherin responsible for host specificity towards the human pathogen Listeria monocytogenes. EMBO J 1999; 18: 3956-3963.
17. Lecuit M, Vandormael-Pournin S, Lefort J et al. A transgenic model for listeriosis: role of internalin in crossing the intestinal barrier. Science 2001; 292: 1722-1725.
18. Thompson RC, Hopkins RM & Homan WL. Nomenclature and genetic groupings of Giardia infecting mammals. Parasitol Today 2000; 16: 210-213.
19. McArthur AG, Morrison HG, Nixon JE et al. The Giardia genome project database. FEMS Microbiol Lett 2000; 189: 271-273.
20. Leitch GJ, Udezulu IA, He Q & Visvesvara GS. Effects of protein malnutrition on experimental giardiasis in the Mongolian gerbil. Scand J Gastroenterol 1993; 28: 885-893.
21. Buret A, Hardin JA, Olson ME & Gall DG. Pathophysiology of small intestinal malabsorption in gerbils infected with Giardia lamblia. Gastroenterology 1992; 103: 506-513.
22. Deselliers LP, Tan DT, Scott RB & Olson ME. Effects of Giardia lamblia infection on gastrointestinal transit and contractility in Mongolian gerbils. Dig Dis Sci 1997; 42: 2411-2419.
23. Astiazaran-Garcia H, Espinosa-Cantellano M, Castanon G, Chavez-Munguia B & Martinez-Palomo A. Giardia lamblia: effect of infection with symptomatic and asymptomatic isolates on the growth of gerbils (Meriones unguiculatus). Exp Parasitol 2000; 95: 128-135.
24. Katelaris PH, Naeem A & Farthing MJ. Attachment of Giardia lamblia trophozoites to a cultured human intestinal cell line. Gut 1995; 37: 512-518.
25. Teoh DA, Kamieniecki D, Pang G & Buret AG. Giardia lamblia rearranges F-actin and α-actinin in human colonic and duodenal monolayers and reduces transepithelial electrical resistance. J Parasitol 2000; 86: 800-806.
26. Eckmann L, Laurent F, Langford TD et al. Nitric oxide production by human intestinal epithelial cells and competition for arginine as potential determinants of host defense against the lumen-dwelling pathogen Giardia lamblia. J Immunol 2000; 164: 1478-1487.
27. Pang G, Buret A, O'Loughlin E, Smith A, Batey R & Clancy R. Immunologic, functional, and morphological characterization of three new human small intestinal epithelial cell lines. Gastroenterology 1996; 111: 8-18.
28. Chin AC, Teoh DA, Scott KG, Meddings JB, Macnaughton WK & Buret AG. Strain-dependent induction of enterocyte apoptosis by Giardia lamblia disrupts epithelial barrier function in a caspase-3-dependent manner. Infect Immun 2002; 70: 3673-3680.
29. Buret AG, Mitchell K, Muench DG & Scott KG. Giardia lamblia disrupts tight junctional ZO-1 and increases permeability in non-transformed human small intestinal epithelial monolayers: effects of epidermal growth factor. Parasitology 2002; 125: 11-19.
30. Heyworth MF. Intestinal IgA responses to Giardia muris in mice depleted of helper T lymphocytes and in immunocompetent mice. J Parasitol 1989; 75: 246-251.
31. Daniels CW & Belosevic M. Serum antibody responses by male and female C57B1/6 mice infected with Giardia muris. Clin Exp Immunol 1994; 97: 424-429.
32. Snider DP & Underdown BJ. Quantitative and temporal analyses of murine antibody response in serum and gut secretions to infection with Giardia muris. Infect Immun 1986; 52: 271-278.
33. Snider DP, Gordon J, McDermott MR & Underdown BJ. Chronic Giardia muris infection in anti-IgM-treated mice. I. Analysis of immunoglobulin and parasite-specific antibody in normal and immunoglobulin-deficient animals. J Immunol 1985; 134: 4153-4162.
34. Snider DP, Skea D & Underdown BJ. Chronic giardiasis in B-cell-deficient mice expressing the xid gene. Infect Immun 1988; 56: 2838-2842.
35. Stager S & Muller N. Giardia lamblia infections in B-cell-deficient transgenic mice. Infect Immun 1997; 65: 3944-3946.
36. Langford TD, Housley MP, Boes M et al. Central importance of immunoglobulin A in host defense against Giardia spp. Infect Immun 2002; 70: 11-18.
37. Skea DL & Underdown BJ. Acquired resistance to Giardia muris in X-linked immunodeficient mice. Infect Immun 1991; 59: 1733-1738.
38. Singer SM & Nash TE. T-cell-dependent control of acute Giardia lamblia infections in mice. Infect Immun 2000; 68: 170-175.
39. Lai Ping So A & Mayer L. Gastrointestinal manifestations of primary immunodeficiency disorders. Semin Gastrointest Dis 1997; 8: 22-32.
40. Burrows PD & Cooper MD. IgA deficiency. Adv Immunol 1997; 65: 245-276.
41. Strober W & Sneller MC IgA deficiency. Ann Allergy 1991; 66: 363-375.
42. Prince HE, Norman GL & Binder WL. Immunoglobulin A (IgA) deficiency and alternative celiac disease-associated antibodies in sera, submitted to a reference laboratory for endomysial IgA testing. Clin Diagn Lab Immunol 2000; 7: 192-196.
43. Briere F, Bridon JM, Chevet D et al. Interleukin 10 induces B lymphocytes from IgA-deficient patients to secrete IgA. J Clin Invest 1994; 94: 97-104.
44. Marconi M, Plebani A, Avanzini MA et al. IL-10 and IL-4 cooperate to normalize in vitro IgA production in IgA-deficient (IgAD) patients. Clin Exp Immunol 1998; 112: 528-532.
45. Harriman GR, Bogue M, Rogers P et al. Targeted deletion of the IgA constant region in mice leads to IgA deficiency with alterations in expression of other Ig isotypes. J Immunol 1999; 162: 2521-2529.
46. Heyworth MF. Relative susceptibility of Giardia muris trophozoites to killing by mouse antibodies of different isotypes. J Parasitol 1992; 78: 73-76.
47. Stager S, Gottstein B, Sager H, Jungi TW & Muller N. Influence of antibodies in mother's milk on antigenic variation of Giardia lamblia in the murine mother-offspring model of infection. Infect Immun 1998; 66: 1287-1292.
48. Singer SM, Elmendorf HG, Conrad JT & Nash TE. Biological selection of variant-specific surface proteins in Giardia lamblia. J Infect Dis 2001; 183: 119-124.
49. Nash TE & Mowatt MR. Characterization of a Giardia lamblia variant-specific surface protein (VSP) gene from isolate GS/M and estimation of the VSP gene repertoire size. Mol Biochem Parasitol 1992; 51: 219-227.
50. Muller N & Gottstein B. Antigenic variation and the murine immune response to Giardia lamblia. Int J Parasitol 1998; 28: 1829-1839.
51. Fang FC. Perspectives series: host/pathogen interactions. Mechanisms of nitric oxide-related antimicrobial activity. J Clin Invest 1997; 99: 2818-2825.
52. Brunet LR. Nitric oxide in parasitic infections. Int Immunopharmacol 2001; 1: 1457-1467.
53. Wallace JL & Miller MJ. Nitric oxide in mucosal defense: a little goes a long way. Gastroenterology 2000; 119: 512-520.
54. Salzman A, Denenberg AG, Ueta I, O'Connor M, Linn SC & Szabo C. Induction and activity of nitric oxide synthase in cultured human intestinal epithelial monolayers. Am J Physiol 1996; 270: G565-G573.
55. Witthoft T, Eckmann L, Kim JM & Kagnoff MF. Enteroinvasive bacteria directly activate expression of iNOS and NO production in human colon epithelial cells. Am J Physiol 1998; 275: G564-G571.
56. Hoffman RA, Zhang G, Nussler NC et al. Constitutive expression of inducible nitric oxide synthase in the mouse ileal mucosa. Am J Physiol 1997; 272: G383-G392.
57. Murray IA, Daniels I, Coupland K, Smith JA & Long RG. Increased activity and expression of iNOS in human duodenal enterocytes from patients with celiac disease. Am J Physiol Gastrointest Liver Physiol 2002; 283: G319-G326.
58. Singer II, Kawka DW, Scott S et al. Expression of inducible nitric oxide synthase and nitrotyrosine in colonic epithelium in inflammatory bowel disease. Gastroenterology 1996; 111: 871-885.
59. Salzman AL, Eaves-Pyles T, Linn SC, Denenberg AG & Szabo C. Bacterial induction of inducible nitric oxide synthase in cultured human intestinal epithelial cells. Gastroenterology 1998; 114: 93-102.
60. Islam D, Veress B, Bardhan PK, Lindberg AA & Christensson B. In situ characterization of inflammatory responses in the rectal mucosae of patients with shigellosis. Infect Immun 1997; 65: 739-749.
61. Fernandes PD & Assreuy J. Role of nitric oxide and superoxide in Giardia lamblia killing. Braz J Med Biol Res 1997; 30: 93-99.
62. Edwards MR, Schofield PJ, O'Sullivan WJ & Costello M. Arginine metabolism during culture of Giardia intestinalis. Mol Biochem Parasitol 1992; 53: 97-103.
63. Knodler LA, Schofield PJ & Edwards MR. L-arginine transport and metabolism in Giardia intestinalis support its position as a transition between the prokaryotic and eukaryotic kingdoms. Microbiology 1995; 141: 2063-2070.
64. Pan M, Malandro M & Stevens BR. Regulation of system y+ arginine transport capacity in differentiating human intestinal Caco-2 cells. Am J Physiol 1995; 268: G578-G585.
65. Mailliard ME, Stevens BR & Mann GE. Amino acid transport by small intestinal, hepatic, and pancreatic epithelia. Gastroenterology 1995; 108: 888-910.
66. Torres ME, Pirez MC, Schelotto F et al. Etiology of children's diarrhea in Montevideo, Uruguay: associated pathogens and unusual isolates. J Clin Microbiol 2001; 39: 2134-2139.
67. Hogaboam CM, Collins SM & Blennerhassett MG. Effects of oral L-NAME during Trichinella spiralis infection in rats. Am J Physiol 1996; 271: G338-G346.
68. Roberts-Thomson IC, Grove DI, Stevens DP & Warren KS. Suppression of giardiasis during the intestinal phase of trichinosis in the mouse. Gut 1976; 17: 953-958.
69. Ouellette AJ & Bevins CL. Paneth cell defensins and innate immunity of the small bowel. Inflamm Bowel Dis 2001; 7: 43-50.
70. Ayabe T, Satchell DP, Pesendorfer P et al. Activation of Paneth cell α-defensins in mouse small intestine. J Biol Chem 2002; 277: 5219-5228.
71. Wilson CL, Ouellette AJ, Satchell DP et al. Regulation of intestinal α-defensin activation by the metalloproteinase matrilysin in innate host defense. Science 1999; 286: 113-117.
72. O'Neil DA, Porter EM, Elewaut D et al. Expression and regulation of the human β-defensins hBD-1 and hBD-2 in intestinal epithelium. J Immunol 1999; 163: 6718-6724.
73. Hase K, Eckmann L, Leopard JD, Varki N & Kagnoff MF. Cell differentiation is a key determinant of cathelicidin LL-37/human cationic antimicrobial protein 18 expression by human colon epithelium. Infect Immun 2002; 70: 953-963.
74. Aley SB, Zimmerman M, Hetsko M, Selsted ME & Gillin FD. Killing of Giardia lamblia by cryptdins and cationic neutrophil peptides. Infect Immun 1994; 62: 5397-5403.
75. Ayabe T, Satchell DP, Wilson CL, Parks WC, Selsted ME & Ouellette AJ. Secretion of microbicidal α-defensins by intestinal Paneth cells in response to bacteria. Nat Immunol 2000; 1: 113-118.
76. Porter EM, Bevins CL, Ghosh D & Ganz T. The multifaceted Paneth cell. Cell Mol Life Sci 2002; 59: 156-170.
77. Turchany JM, Aley SB & Gillin FD. Giardicidal activity of lactoferrin and N-terminal peptides. Infect Immun 1995; 63: 4550-4552.
78. Tedeschi A, Tuccari G, Magazzu G, Arena F, Ricciardi R & Barresi G. Immunohistochemical localization of lactoferrin in duodenojejunal mucosa from celiac children. J Pediatr Gastroenterol Nutr 1987; 6: 328-334.
79. Mason DY & Taylor CR. Distribution of transferrin, ferritin, and lactoferrin in human tissues. J Clin Pathol 1978; 31: 316-327.
80. Hill DR & Pearson RD. Ingestion of Giardia lamblia trophozoites by human mononuclear phagocytes. Infect Immun 1987; 55: 3155-3161.
81. Heyworth MF, Owen RL, Seaman WE, Schaefer FW 3rd & Jones AL. Harvesting of leukocytes from intestinal lumen in murine giardiasis and preliminary characterization of these cells. Dig Dis Sci 1985; 30: 149-153.
82. Heyworth MF, Owen RL & Jones AL. Comparison of leukocytes obtained from the intestinal lumen of Giardia-infected immunocompetent mice and nude mice. Gastroenterology 1985; 89: 1360-1365.
83. Heyworth MF, Carlson JR & Ermak TH. Clearance of Giardia muris infection requires helper/inducer T lymphocytes. J Exp Med 1987; 165: 1743-1748.
84. Heyworth MF, Kung JE & Eriksson EC. Clearance of Giardia muris infection in mice deficient in natural killer cells. Infect Immun 1986; 54: 903-904.
85. Zhou P, Li E, Zhu N, Robertson J, Nash T & Singer SM. Role of Interleukin-6 in the control of acute and chronic Giardia lamblia infections in mice. Infect Immun 2003; 71: 1566-1568.
86. Bienz M, Dai WJ, Welle M, Gottstein B & Muller N. Interleukin-6-deficient mice are highly susceptible to Giardia lamblia infection but exhibit normal intestinal immunoglobulin A responses against the parasite. Infect Immun 2003; 71: 1569-1573.
87. Perez PF, Minnaard J, Rouvet M et al. Inhibition of Giardia intestinalis by extracellular factors from Lactobacilli: an in vitro study. Appl Environ Microbiol 2001; 67: 5037-5042.